Insider Transactions in Q2 2022 at Cortexyme, Inc. (CRTX)
Insider Transaction List (Q2 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 06
2022
|
Caryn Gordon Mc Dowell Chief Legal & Adm. Officer |
SELL
Open market or private sale
|
Direct |
10,800
-8.1%
|
$21,600
$2.86 P/Share
|
|
Jun 06
2022
|
Caryn Gordon Mc Dowell Chief Legal & Adm. Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
6,700
-4.79%
|
$13,400
$2.86 P/Share
|
|
Jun 06
2022
|
Leslie Holsinger EVP, Preclinical Development |
SELL
Payment of exercise price or tax liability
|
Direct |
10,920
-6.87%
|
$21,840
$2.86 P/Share
|
|
Jun 06
2022
|
Ted Monohon Chief Accounting Officer & VP |
SELL
Payment of exercise price or tax liability
|
Direct |
1,529
-4.5%
|
$4,587
$3.12 P/Share
|
|
May 19
2022
|
Brendan Hannah CHIEF BUSINESS OFFICER AND COO |
BUY
Grant, award, or other acquisition
|
Direct |
16,224
+50.0%
|
-
|
|
May 19
2022
|
David Lamond |
BUY
Grant, award, or other acquisition
|
Indirect |
200,002
+10.34%
|
-
|
|
May 19
2022
|
Philip S Low Director |
BUY
Grant, award, or other acquisition
|
Indirect |
63,974
+50.0%
|
-
|
|
May 19
2022
|
Philip S Low Director |
BUY
Grant, award, or other acquisition
|
Direct |
455,309
+50.0%
|
-
|
|
May 19
2022
|
Karen L. Smith Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
24,336
+50.0%
|
-
|
|
May 19
2022
|
Dirk Thye CEO AND CHIEF MEDICAL OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
64,589
+50.0%
|
-
|